Biclotymol

Biclotymol is an antimicrobial agent against gram-positive cocci. Biclotymol inhibits Streptococcus pneumoniae and Haemophilus influenzae, with MIC of 150 and 150 μM. Biclotymol exhibits anti-inflammatory and analgesic activity and ameliorates the otolaryngology infection and throat sore[1].

Product Specifications

CAS Number

[15686-33-6]

UNSPSC

12352005

Hazard Statement

H302-H315-H319-H335

Target

Bacterial; Fungal

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/biclotymol.html

Solubility

10 mM in DMSO

Smiles

ClC1=C(C)C(CC2=C(C(C(C)C)=CC(Cl)=C2C)O)=C(O)C(C(C)C)=C1

Molecular Formula

C21H26Cl2O2

Molecular Weight

381.34

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Karpova E, et al., Role of biclotymol-based products in the treatment of infectious sore throat. Eur Rev Med Pharmacol Sci. 2017 Aug;21 (16) :3736-3743.